DENTSPLY SIRONA

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic and orthodontic dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Dentsply Sirona (XRAY) exceeds Q4 expectations, focuses on innovation

Dentsply Sirona (XRAY) reported strong financial performance in Q4 2022, with a strategic focus on digitalization and innovation. Despite challenges in organic sales and supply chain constraints, the company aims for margin improvement and growth opportunities through investments and pricing strategies. Restructuring efforts and acquisitions are set to drive profitability and market share gains.

Dentsply Sirona reports robust Q1 growth, eyes digital innovation

Dentsply Sirona's strong Q1 performance driven by Consumables and Aligners segments.
Challenges include mixed regional performance and cautious outlook on equipment demand.
Opportunities lie in digitalization, DSO partnerships, and growth in China and EPS targets.
Overall, a positive outlook with strategic focus on innovation and customer experience.

Dentsply Sirona exceeds Q2 expectations, eyes growth amid challenges

Dentsply Sirona reported strong financial performance in Q2 2023, exceeding expectations and raising full-year outlook across key financial metrics.
The company's strategic focus on growth, profitability, and digitalization, coupled with investments in key regions and product innovation, positions it for sustained success.
While facing challenges in certain markets and operational areas, Dentsply Sirona remains optimistic about opportunities for growth, innovation, and value creation in the dental industry.
Overall, Dentsply Sirona's performance highlights operational strengths, market positioning, and a forward-looking approach to driving shareholder value and market expansion.

DENTSPLY SIRONA reports mixed Q3 results, focuses on innovation and growth

DENTSPLY SIRONA's Q3 performance showed mixed results with challenges in certain markets but strength in key segments like CAD/CAM and Aligners.
The company is focused on driving value through innovation, maintaining a commitment to long-term plans, and navigating external challenges with confidence.
Despite headwinds, DENTSPLY SIRONA remains within guidance range for the year, with a strategic focus on volume growth and market expansion opportunities.

DENTSPLY SIRONA anticipates double-digit EPS growth in 2024

DENTSPLY SIRONA's Q4 2023 performance showed growth in key segments, with strategic initiatives set for 2024 as an inflection year for double-digit EPS growth.
The company is focusing on innovation, SKU optimization, and operational efficiency to drive profitability and revenue growth.
Challenges lie in certain segments and the need for organic growth normalization by 2025, but opportunities exist in new product launches and margin expansion.
Overall, DENTSPLY SIRONA is poised for accelerated profitable growth, with 2024 expected to be a pivotal year for improved performance.

DENTSPLY SIRONA reports mixed Q1 performance amidst innovation focus

DENTSPLY SIRONA navigated challenges in Q1 with a focus on innovation, sustainability, and strategic updates. While facing headwinds in certain segments and markets, the company aims to capitalize on growth opportunities through product launches and strategic initiatives.

DENTSPLY Sirona navigates revenue decline with strategic restructuring plans

DENTSPLY Sirona's Q2 performance reflects revenue decline and margin contraction, prompting strategic restructuring and focus on customer-centric initiatives. While facing challenges from macroeconomic factors and restructuring impacts, the company aims to leverage opportunities in shareholder returns and market dynamics to drive growth and operational efficiency.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

CHARLOTTE, N.C., July  22, 2020  (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live webcast on Thursday, August 6, 2020 at 8:00 am ET and send out an earnings press release earlier that morning. A presentation related to the call will be available on www.dentsplysirona.com in the Investors section.

Dentsply Sirona to Host Second Quarter 2020 Conference Call on August 6th

CHARLOTTE, N.C., June  24, 2020  (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), The Dental Solutions Company, today announced that on Tuesday, June 23rd, 2020 the United States District Court for the District of New Mexico, in a ruling by Judge Joseph F. Bataillon, held that EdgeTaper Encore endodontic files sold by US Endodontics and Edge Endo infringe at least three valid claims of patents asserted by Dentsply Sirona Inc.  Judge Bataillon granted Dentsply Sirona’s motion for summary judgment that each of the three patent claims were infringed by EdgeTaper Encore and that Dentsply Sirona’s three patent claims are valid.  The Court also rejected Edge’s request to dismiss Dentsply Sirona’s claim that Edge’s infringement was willful.  A finding of willful infringement allows the Court to award treble damages and attorneys’ fees against an adjudicated infringer.

Dentsply Sirona Inc. wins Summary Judgment against Edge Endo and US Endodontics in Patent Infringement Case

Danaher

Medtronic

On 6/25/20, Danaher, DENTSPLY SIRONA and Medtronic will all trade ex-dividend for their respective upcoming dividends.

Ex-Dividend Reminder: Danaher, DENTSPLY SIRONA And Medtronic

AmerisourceBergen

Align Technology

Becton, Dickinson and Co.

Cardinal Health

Cooper Companies

Henry Schein

Labcorp Holdings Inc

McKesson

Patterson Companies

Near-Term Outlook Bleak for Medical Dental Supplies Industry

Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock?

Dentsply (XRAY) Up 22.2% Since Last Earnings Report: Can It Continue?

DENTSPLY SIRONA Inc. (XRAY) CEO Don Casey on Q1 2020 Results - Earnings Call Transcript

Shares of Dentsply Sirona (NASDAQ:XRAY) rose 2% after the company reported Q1 results.

Recap: Dentsply Sirona Q1 Earnings

DENTSPLY SIRONA's (XRAY) first-quarter 2020 preliminary results reflect weak segmental performance and decline in revenues.

DENTSPLY SIRONA (XRAY) Posts Weak Q1 Preliminary Results

Dentsply (XRAY) delivered earnings and revenue surprises of 4.88% and -0.29%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Dentsply International (XRAY) Q1 Earnings Surpass Estimates

Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Dentsply International (XRAY) Q1 Earnings Expected to Decline

American States Water

Kroger

McDonald's

Public Storage

Wyndham Hotels & Resorts Inc

U.S. payroll numbers in March were lackluster. We have highlighted a few industries that survived the coronavirus threat in March and also the ones that succumbed.

First US Payroll Crash Since 2010: What's Hot, What's Not

Dentsply (XRAY) Down 17.8% Since Last Earnings Report: Can It Rebound?

DENTSPLY SIRONA Inc. (XRAY) CEO Don Casey on Q4 2019 Results - Earnings Call Transcript

DENTSPLY SIRONA (XRAY) gains from the Technologies & Equipment arm in Q4.

DENTSPLY SIRONA (XRAY) Q4 Earnings Lag Estimates, Sales Rise

Dentsply (XRAY) delivered earnings and revenue surprises of -1.35% and 2.11%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Dentsply International (XRAY) Q4 Earnings Lag Estimates

CHARLOTTE, N.C., Feb.  28, 2020  (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY), The Dental Solutions Company™, announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share of common stock, an indicated annual rate of $0.40 per share.  The dividend is payable on April 10, 2020 to holders of record on March 27, 2020.

Dentsply Sirona Declares  Quarterly Cash Dividend

CONMED

XRAY vs. CNMD: Which Stock Is the Better Value Option?

Alaska Air Group

Dollar General

Applied Materials

D.R. Horton

Qorvo

Take-Two Interactive Software

Investing and romance may not go hand in hand. But finding attractively valued stocks with dependable sales and earnings growth can make some hearts go pitter-patter.

Facebook, Dollar General, Alaska Air and more stocks to love

XRAY or CNMD: Which Is the Better Value Stock Right Now?

Canopy Growth

Twenty-First Century Fox

Alphabet

Intuit

CarMax

Twitter

One of the biggest stories on Wall Street in 2020 will be the U.S. presidential election in November.

8 Stocks To Buy For This 2020 Presidential Election Year

Dentsply (XRAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Dentsply (XRAY) Soars to 52-Week High, Time to Cash Out?

Delta Air Lines

Global Payments

H&R Block

Lockheed Martin

Lamb Weston Hlds

Mylan

Raytheon

T. Rowe Price Group

The rally has been broad based and there are winners across various corners of the space.

10 Top-Ranked S&P 500 Stocks Outperforming in 2020

American Electric Power Company

Citigroup

Disney

Intel

Kimco Realty

Tyson Foods

WestRock

Exxon Mobil

With 2019 as an incredible year for stocks to act as a capstone on the decade, investors better stop looking backward and start looking into 2020 and beyond.

11 Top Merrill Lynch Stock Picks for 2020

Amgen

UnitedHealth Group

After a year of sector underperformance, several factors are coalescing to make 2020 a better year for the health care sector, Goldman Sachs said Monday as it added three stocks to its conviction list.

Goldman Sachs Adds Amgen, UnitedHealth, Dentsply Sirona To Conviction List

Health care remains a political hot button. Despite the Affordable Care Act, there remains a push and pull in the industry over which companies can survive and which ones can thrive in the decade ahead.

Goldman Sachs Has 3 Top Health Care Stocks to Outperform in 2020

News for DENTSPLY SIRONA Stock (XRAY)